MG
ALT icon

Michael Gelband’s Altimmune ALT Stock Holding History

Michael Gelband’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-48,619
Closed -$150K – 1536
2026
Q1 		$150K Buy
48,619
+36,698
+308% +$156K ﹤0.01% 1408
2025
Q4 		$43K Sell
11,921
-166,256
-93% -$725K ﹤0.01% 1457
2025
Q3 		$672K Buy
178,177
+138,918
+354% +$536K 0.01% 1095
2025
Q2 		$152K Sell
39,259
-1,668
-4% -$9.03K ﹤0.01% 1336
2025
Q1 		$205K Buy
+40,927
New +$259K ﹤0.01% 1294
2024
Q4 		– Sell
-45,769
Closed -$281K – 1475
2024
Q3 		$281K Buy
45,769
+28,259
+161% +$191K ﹤0.01% 1381
2024
Q2 		$116K Sell
17,510
-63,403
-78% -$468K ﹤0.01% 1419
2024
Q1 		$824K Buy
+80,913
New +$823K 0.01% 1004
2022
Q3 		– Sell
-305,879
Closed -$3.58M – 1847
2022
Q2 		$3.58M Buy
305,879
+279,528
+1,061% +$1.72M 0.04% 528
2022
Q1 		$160K Buy
+26,351
New +$194K ﹤0.01% 1948
2021
Q4 		– Sell
-74,358
Closed -$841K – 2128
2021
Q3 		$841K Buy
74,358
+62,717
+539% +$763K 0.01% 1109
2021
Q2 		$115K Sell
11,641
-65,007
-85% -$889K ﹤0.01% 2123
2021
Q1 		$1.08M Buy
76,648
+59,435
+345% +$961K 0.02% 871
2020
Q4 		$194K Buy
+17,213
New +$203K ﹤0.01% 1740
2020
Q3 		– Sell
-23,400
Closed -$251K – 1708
2020
Q2 		$251K Buy
+23,400
New +$129K 0.01% 1407

Other funds holding ALT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Michael Gelband's ALT Position: Q2 2026 in Review

Michael Gelband sold out of Altimmune (ALT) in Q2 2026, closing a stake of 48,619 shares — an estimated $150K sold.

Michael Gelband first reported a position in ALT in Q2 2020 and held it in 15 quarters. The position peaked at $3.58M in Q2 2022. 209 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • Michael Gelband reported no remaining Altimmune position as of Q2 2026 after selling out during the quarter.
  • Michael Gelband sold 48,619 Altimmune shares in Q2 2026, an estimated $150K.
  • Michael Gelband first reported a position in Altimmune in Q2 2020 and held it in 15 quarters.
  • Michael Gelband's Altimmune position peaked at $3.58M in Q2 2022.
  • 209 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.